Skip to main navigation Skip to search Skip to main content

ACTR-26. SAFETY AND EFFICACY OF BEVACIZUMAB PLUS TTFIELDS IN PATIENTS WITH RECURRENT GLIOBLASTOMA (GBM): DATA FROM A PHASE II CLINICAL TRIAL

  • Jaleh Fallah
  • , Rekha Chaudhary
  • , Lisa Rogers
  • , Wei Wei
  • , Cathy Brewer
  • , David Peereboom
  • , Manmeet Ahluwalia

Research output: Contribution to conference › Presentation

Original languageAmerican English
DOIs
StatePublished - Nov 11 2019
EventNeuro-oncology -
Duration: Nov 11 2019 → …

Conference

ConferenceNeuro-oncology
Period11/11/19 → …

Disciplines

  • Medicine and Health Sciences
  • Oncology
  • Internal Medicine

Cite this